SAFLUTAN 15mcg / ml ophthalmic drops solution medication leaflet

S01AE05 tafluprost • Sensory organs | Antiinfectives | Fluoroquinolones

Tafluprost is a prostaglandin analog used for the treatment of open-angle glaucoma and ocular hypertension. It lowers intraocular pressure by increasing the outflow of aqueous humor from the eye.

The medication is administered as eye drops, usually once daily, as directed by a doctor. It is important for patients to follow the usage instructions to achieve maximum efficacy.

Patients should be aware of potential side effects, such as eye irritation, redness, or changes in iris pigmentation. It is important to inform the doctor of any unusual symptoms.

Common side effects include eye irritation, a burning or itching sensation, and gradual changes in iris color. In rare cases, allergic reactions or ocular inflammation may occur. Patients should be informed of these risks before starting treatment.

General data about SAFLUTAN 15mcg / ml

Substance: tafluprost

Date of last drug list: 01-03-2023

Commercial code: W65332003

Concentration: 15mcg / ml

Pharmaceutical form: ophthalmic drops solution

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SANTEN OY - FINLANDA

Holder: SANTEN OY - FINLANDA

Number: 10861/2018/03

Shelf life: 3 years-after packing for marketing;after openinga a flac.-3 months

Pharmaceutical forms available for tafluprost

Other substances similar to tafluprost

Combinations with other substances